Role of a hyaluronate-based membrane in the prevention of peritonitis-induced adhesions.
Adhesions remain a significant postoperative complication of abdominal surgery; however, recent evidence suggests that physical barriers may reduce their incidence. Although these adhesion prevention barriers are efficacious when used under aseptic conditions, little is known about their use in the presence of peritonitis, which is associated with an increased incidence of abdominal adhesions. A sodium hyaluronate and carboxymethylcellulose bioresorbable membrane (HA membrane) has been shown recently to reduce postoperative adhesions in several animal models and in two clinical trials. To investigate the efficacy of HA membrane in the presence of peritonitis, generalized peritonitis was induced in rats by either cecal ligation and puncture (CLP) or cecal ligation (CL) alone. The ceca were resected after 12 hours, and animals were randomly assigned to receive or not receive HA membrane applied to the cecum. At day 7, abdominal adhesions and abscesses were scored. In the presence of peritonitis, HA membrane did not significantly reduce the number or tenacity of adhesions. A trend toward increased abscess formation was associated with HA membrane in the CL group. Although HA membrane has been shown to reduce the incidence and severity of abdominal adhesions under aseptic conditions, this study demonstrates that it is not efficacious in preventing abdominal adhesions in the presence of peritonitis. The association between HA membrane and abscess formation in the presence of experimental peritonitis requires further investigation.
Ghellai
A M
AM
Department of Surgery, Boston University School of Medicine, MA 02118, USA.
Stucchi
A F
AF
Lynch
D J
DJ
Skinner
K C
KC
Colt
M J
MJ
Becker
J M
JM
D000038:Abscess / Q000209:etiology / Q000517:prevention & control; D000818:Animals; D002266:Carboxymethylcellulose Sodium; D002432:Cecum / Q000601:surgery; D016009:Chi-Square Distribution; D005260:Female; D006820:Hyaluronic Acid; D008567:Membranes, Artificial; D010538:Peritonitis / Q000150:complications*; D011183:Postoperative Complications / Q000517:prevention & control*; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D000267:Tissue Adhesions / Q000209:etiology / Q000517:prevention & control*
D008567:Membranes, Artificial; D006820:Hyaluronic Acid; D002266:Carboxymethylcellulose Sodium